That's important, because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be effective. To put it simply, we need to know how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (biotech stocks). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're designed to do. This was an advancement practically no one noticed. But it's going to have profound implications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of financial investment chances in this space, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (future report). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back maybe substantially prior to going greater - second wave. I've been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. However that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. jeff brown biotech pick. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of great private business on the edge of hitting the general public markets And I've been dealing with a new method for you to invest even before these companies go public.
This opportunity has been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your area free of charge.
Emma Walsh here, managing editor of the Journal. Regular Diary readers understand that tech isn't our usual beat (jeff bezos). And when it pertains to tech investing, we leave it to the professionals. Luckily, we have several such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we understand (future report). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big photo and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These patterns are experiencing exponential development and creating incredible chances for investors. I want to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. biotech stock. But regardless of what lots of readers might think, this is a trend that's just beginning. Even though the COVID-19 pandemic disrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown 1 biotech company). Losing 2 months of production and sales actually impacts the number of 5G devices are sold in the calendar year. When you think about all of that, offering 250 million systems is impressive. More importantly, the delays brought on by the pandemic developed a lots of bottled-up need. And that demand is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - exponential tech investor. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I've explained its three various phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage Three, 5G services start to be used (jeff brown top stock pick 2021). That's when we begin to see applications working on 5G networks. Believe of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase Three by this summer. This begins something of a virtuous cycle: The majority of people don't really care about the innovation. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The investment chances moving forward will be enormous. Stepping far from 5G, the next crucial innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a similar idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And throughout that time, there were really only 3 business running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating illness and seeing that this technology just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire market is successfully a greenfield opportunity.
There's room for many business to exist in this space. brownstone research stock. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software can properly predict the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is essential due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has been an experimental procedure. However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced using this innovation. This was among those developments that nearly no one discovered. But it's going to have extensive ramifications for treating illness. And, of course, there will be lots of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back perhaps substantially before going higher. I've been covering bitcoin for a long time now. Among the very first research reports I ever released was on bitcoin - longtime readers. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff brown stock predictions. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date since February 2021, but we might not separately confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like ability to choose winning technology stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an excellent perspective on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares numerous of his finest picks in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully predicted some of the biggest economic events of the past twenty years. Although he does not appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right every time, however Jeff Brown's precise forecasts have actually earned him legions of devoted followers. That says a lot about his ability. The Near Future Report is published by Brownstone Research, a prominent financial research study publisher. Brownstone Research provides numerous research services with a variety of expertises - jeff brown market predictions.
The business is also connected with Bonner & Partners, another well-respected research study publisher - genetic sequencing companies jeff brown. On its site, Brownstone states its objective is to provide retail investors with professional-grade research study: "For too long, the best financial investment research has actually not been available to specific investors. It has actually been typically scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. diplomatic relations. The mission of Brownstone Research study is to make that type of proprietary research study readily available to any financiers aiming to get an edge in the markets. The objective is basic to provide unique and profitable investment research discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise functions as the company's Chief Investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout most of America. If you know even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. jeff brown investor prediction. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. future report review. could be "the most significant pattern of the 2020s, and he's not alone. Inspect out these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding two cutting-edge innovations: artificial intelligence and electrical automobiles. Musk hopes the combination will assist him develop the first fully-autonomous, self-driving vehicles ever. It's nothing except the automotive industry's Holy Grail. As you understand, electrical vehicles and self-driving car stocks have been substantial this year, but the Wall Street machine has approved hype without much tangible outcome. Regardless of an extreme boost in competitors over the previous few years, Brown still thinks Musk has the best opportunity of putting everything together.
tech might be the magic string that connects it all together. S.A.V. represents Shared Autonomous Car, and it could be the future of transportation. Basically, this technology would allow you to lease your vehicle as a self-governing, self-driving taxi when you're not using it. You just get out of the automobile and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the earnings. It sounds outrageous, but it could be closed than you think.